Jefferies Upgrades IBM, Citing 2026 AI and Cloud Growth Potential




05.01.26 14:38
Börse Global (en)

IBM Aktie

In a significant shift in outlook, analysts at Jefferies have upgraded their rating for International Business Machines Corp. (IBM). The firm moved its recommendation from "Hold" to "Buy," simultaneously lifting its price target from $300 to $360 per share. This new target implies an upside of more than 20% from recent trading levels, with the bank highlighting the company's strategic positioning in enterprise artificial intelligence and hybrid-cloud infrastructure.


Strategic Positioning for Acceleration


The upgrade forms part of a broader sector analysis by Jefferies, which advises an underweight stance on software overall, citing a loss of momentum relative to semiconductors. IBM is presented as the standout exception to this cautious view. Analyst Brent Thill identified the company as a 2026 "acceleration story" and a top software sector pick for the coming year, based on expectations for continued software business growth.


Jefferies anticipates another year of "gradual" AI monetization in 2026. The bank views IBM as well-positioned to capture demand from large corporate clients, favoring infrastructure providers over pure-play application vendors. IBM's watsonx platform and recent strategic acquisitions are seen as aligning perfectly with this investment thesis.


A cornerstone of this strategy is the planned $11 billion acquisition of Confluent, announced in December 2025 and expected to close by mid-2026. The deal is poised to bring critical real-time data streaming technology into IBM's portfolio, a capability considered central for enterprise AI applications and a significant reinforcement of its data infrastructure.


Financial Performance and Market Context


The optimistic call from Jefferies adds to a generally improving analyst sentiment. Recent quarterly results have supported this constructive view.


Q3 2025 Financial Highlights:
* Earnings Per Share (EPS): $2.65, surpassing the consensus estimate of $2.45.
* Revenue: $16.33 billion, exceeding expectations of $16.10 billion.
* Year-over-Year Revenue Growth: 9.1%.


This growth was primarily fueled by sustained demand for hybrid-cloud solutions and AI offerings, with the Software and Consulting segments leading the performance.


Current Analyst Consensus & Valuation:
* Consensus Rating: Moderate Buy
* Average Price Target: $293.38
* Price Target Range: $252 (Morgan Stanley) to $360 (Jefferies, Oppenheimer)


Selected analyst positions include:
* Oppenheimer: Initiated coverage with "Outperform" and a $360 target (November 2025).
* Bank of America: "Buy" rating with a $315 target.
* Royal Bank of Canada: "Outperform," though target reduced from $315 to $300.
* UBS Group: Maintains a "Sell" rating.
* Morgan Stanley: "Equal Weight" with a $252 target.


On the market, IBM shares have demonstrated robust performance, gaining approximately 33% over the past twelve months. This outpaces the gains of Microsoft (+14.2%) and Amazon (+2.9%). After a modest pullback of about 5% from recent highs, the stock closed near $291 on Friday.


Key Valuation Metrics:
* P/E Ratio: 34.85
* Market Capitalization: Approximately $272 billion
* Dividend Yield: 2.3% ($6.72 per share annually)
* 52-Week Range: $214.50 to $324.90


Forward-Looking Catalysts


Several near- and medium-term catalysts are in focus for investors.


Q4 2025 Earnings (January 28):
IBM is scheduled to report fourth-quarter 2025 results after the market closes on January 28. The current market consensus projects EPS of $4.31. Notably, full-year 2025 earnings expectations have risen by 15.4% over the past twelve months to $12.24 per share. Early estimates for 2026 sit at $13.07, representing a projected year-over-year increase of 16.3%.


Strategic Priorities for 2026:
The coming year is expected to be defined by several key initiatives:
* Confluent Integration: The anticipated mid-2026 closure and subsequent integration aimed at expanding AI data infrastructure capabilities.
* Quantum Computing Advancements: IBM has labeled 2026 as the year for "Quantum Advantage," where its quantum computers are projected to surpass classical systems on specific tasks.
* watsonx Platform Expansion: Further enterprise adoption and monetization of the company's flagship AI platform.


The upgraded rating and heightened price target from Jefferies signal growing confidence in IBM's ability to execute this strategic roadmap, reinforcing its status as a leading candidate for exposure to enterprise AI infrastructure in 2026.


Ad


IBM Stock: New Analysis - 05 January

Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.


Read our updated IBM analysis...








 
 
hier klicken zur Chartansicht

Aktuelle Kursinformationen mehr >
Kurs Vortag Veränderung Datum/Zeit
199,06 € 197,70 € 1,36 € +0,69% 24.04./09:57
 
ISIN WKN Jahreshoch Jahrestief
US4592001014 851399 280,90 € 187,78 €
Handelsplatz Letzter Veränderung  Zeit
 
Tradegate (RT)
199,06 € +0,69%  09:54
Düsseldorf 198,00 € +1,42%  08:10
Frankfurt 198,32 € +0,46%  08:06
Stuttgart 198,40 € +0,33%  09:31
Hannover 198,02 € +0,17%  08:03
Xetra 198,50 € +0,03%  09:42
Nasdaq 230,94 $ +0,01%  23.04.26
NYSE 231,08 $ 0,00%  01:00
AMEX 232,05 $ -0,11%  23.04.26
München 198,76 € -0,31%  08:02
Hamburg 197,68 € -8,90%  23.04.26
  = Realtime
Aktien des Tages

Meistgelesene Artikel
Aktuelle Diskussionen
Antw. Thema Zeit
759 IBM buy 23.04.26
22 Al: wenn das so weitergeht, se. 25.04.21
23 VERZWEIFELT 25.04.21
3 welchen put auf IBM würdet ih. 25.04.21
9 SINO-I.COM ??? 25.04.21
RSS Feeds




Bitte warten...